Results 221 to 230 of about 66,203 (260)

Development and psychometric properties of a general cancer stigma scale

International Journal of Cancer, Volume 158, Issue 10, Page 2747-2759, 15 May 2026.
What's New? Cancer‐related stigma can fuel anxiety and depression and lead to self‐isolation, delayed treatment, and decreased quality of life. The extent to which stigma impacts cancer patients, however, remains uncertain. This study applied mixed methods in high‐ and low‐income settings, with cohorts in the U.S. state of Utah and Lilongwe, Malawi, to
Stephen M. Kimani, Gita Suneja, Agatha Bula, Chaorong Wu, Abhilasha Khatri, Nehal Bakshi, Olivia R. Hanson, Aparna Mangadu, Mercy Tsidya, Melissa A. Stockton, Brandon A. Knettel, Melissa H. Watt   +11 more
wiley   +1 more source

Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral Immunity. [PDF]

Int J Mol Sci
Vlaming KE, Jansen J, de Bree GJ, Kootstra NA, Geijtenbeek TBH.   +4 more
europepmc   +1 more source

The immunosuppressive tuberculosis-associated microenvironment inhibits viral replication and promotes HIV-1 latency in CD4⁺ T cells. [PDF]

iScience
Cronin S, de Vries-Egan A, Vahlas Z, Czernikier A, Melucci C, Pereyra Gerber P, O'Neil T, Gloss B, Sharabas M, Turk G, Verollet C, Balboa L, Palmer S, Duette G.   +13 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

iTRAQ-based proteomic study on monocyte cell model discovered an association of LAMP2 downregulation with HIV-1 latency. [PDF]

Proteome Sci
Yin L, Wang Q, Liu S, Chen J, Zhang Y, Lu L, Lu H, Song Z, Zhang L.   +8 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents. [PDF]

ACS Med Chem Lett
Wang YK, Huang XS, Sun H, Ma MD, Yu HP, Hu W, Li ZY, Li Z, Luo RH, Tian RR, Xiao TF, Yang LM, Zheng YT, Li X.   +13 more
europepmc   +1 more source

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

, 2022
Prins H, Crespo R, Lungu C, Rao S, Li L, Overmars R, Papageorgiou G, Mueller Y, Hossain T, Kan T, Rijnders B, Bax H, van Gorp E, Nouwen J, de Vries-Sluijs T, Schurink C, de Mendonça Melo M, van Nood E, Colbers A, Burger D, Palstra R, van Kampen J, van de Vijver D, Mesplède T, Katsikis P, Gruters R, Koch B, Verbon A, Mahmoudi T, Rokx C.   +29 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mechanisms of HIV-1 latency

AIDS, 1992
This review describes some of the virus-cell relationships that might contribute to the state of latency observed in HIV infection. Viruses use many mechanisms to persist in their host, and the molecular interactions evoked by the virus and the cell on each other can influence the outcome of an infection.
D P, Bednarik, T M, Folks
openaire   +2 more sources

Cellular Latency in HIV-1 Infection

Clinics in Laboratory Medicine, 1994
There are multiple levels of transcriptional regulation that a cell can bring to bear on either native cellular genes or integrated proviral genes. One such level of regulation is inducible sequence-specific transcriptional factors, such as NF-kappa B, which have been extensively investigated with respect to the HIV-1 LTR.
M A, Laughlin, R J, Pomerantz
openaire   +2 more sources